1 Min Read
May 11 (Reuters) - Xvivo Perfusion AB:
* XVIVO PERFUSION HAS SUBMITTED PREMARKET APPROVAL APPLICATION FOR XPS WITH STEEN SOLUTION TO FDA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.